Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 4,664

Document Document Title
WO/2007/019345
Provided herein are imidazopyridine derivatives of formulas ((XIV), (XV),(XVI) and (XVII) which are sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a ce...  
WO/2007/016864
Use of fructus schisandrae in preparation of medicaments for preventing and decreasing toxic and side effects of antineoplastic drugs. Said toxic and side effects of antineoplastic drugs are antineoplastic drugs-induced cardiovascular to...  
WO/2007/017146
The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment and/or prevention of oxidative stress-induced d...  
WO/2007/019417
Provided herein are oxazolopyridine derivatives which are sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasingthe lifespan of a cell, and treating and/or preventing a wide v...  
WO/2007/017146
The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment and/or prevention of oxidative stress-induced d...  
WO/2007/018475
This invention is in the field of snake venom and the invention provides two novel snake polypeptides and nucleic acids encoding the same. Also provided are various uses methods and compositions based on the discovery of the novel snake ...  
WO/2007/018226
Disclosed is a pharmaceutical for the prevention and/or treatment of a corneal disorder. Also disclosed is a corneal protective agent. A pharmaceutical for the prevention and/or treatment of a corneal disorder comprising a pyrazolone der...  
WO/2007/019344
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorder...  
WO/2007/009187
A food additive composition including a polyphenol , such as a polyphenol containing product derived from grape seed, apple, pear, green tea or cocoa extracts, in combination with a probiotic, such as a probiotic selected from lactobacil...  
WO/2007/009092
This disclosed method improves the accuracy of testing blood for the levels of contaminants, such as lead, cadmium and mercury, in individuals. The method comprises cleaning the area where the skin will be penetrated to obtain the blood ...  
WO/2007/001006
It is intended to provide a drug for ameliorating symptoms or diseases caused by heavy metals (for example, Wilson’s disease, heavy metal toxication, aging, fulminant hepatitis and so on) which has a high safety without any fear of sid...  
WO/2007/001080
A beverage/food or pharmaceutical comprising a loquat leaf or an extract or purified product from a loquat leaf as an active ingredient and has one or more effects selected from the group consisting of an antihyperlipemic effect, an anti...  
WO/2006/138571
The application relates, in part, to a therapeutic composition comprising a pharmaceutically active agent and a diarrheagenic agent.  
WO/2006/134970
Disclosed is a coenzyme Q10-containing water-soluble composition which can retain a stable emulsified state for a prolonged time of period at a temperature ranging from a low temperature to ambient temperature and has a high bioavailabil...  
WO/2006/132205
Disclosed are clinically very useful novel radical scavenger, active oxygen eliminating agent and the like. The radical scavenger and active oxygen eliminating agent contain a 3,4-dihydroxyphenylalanine derivative such as N-β-alanyl-5-S...  
WO/2006/132438
A compound represented by the formula (I) or a salt thereof: (I) wherein R1 independently represents a halogen atom, a hydroxy, a nitro, an alkyl, alkenyl or alkynyl which may be halogenated, an alkoxy which may have a substituent, an ac...  
WO/2006/129524
[PROBLEMS] To provide a carbonyl compound remover with a high carbonyl compound removing capability and a high inhibitory effect on accompanying AGEs formation; a remover in which a property of not trapping vitamin B6 is conferred to the...  
WO/2006/129323
The invention relates to the best mode of deriving optimal benefits from administration of Curcumin in human beings through innovatively enhanced bio-availability achieved through optimally admixing an innovatively derived portion of a v...  
WO/2006/128253
There is provided drug delivery systems for bioactive substances. In particular, there is provided a chocolate product containing bioactive compounds as well as desirable flavours and deliverability.  
WO/2006/128618
The present invention relates to novel formulations comprising lipoic acid and hyaluronic acid and/or the derivatives thereof for use in the repair of chronic ulcers, the regeneration of damaged skin, the prevention of skin aging and, wh...  
WO/2006/126895
A composition containing bark extract from the genus Pinus is described to improve, or prevent a decline in, human cognitive abilities or improve, or prevent symptoms of, neurological disorders in a human. The composition is advantageous...  
WO/2006/126895
A composition containing bark extract from the genus Pinus is described to improve, or prevent a decline in, human cognitive abilities or improve, or prevent symptoms of, neurological disorders in a human. The composition is advantageous...  
WO/2006/126675
A melanin formation suppressor and/or an elastase activity inhibitor comprising, as the active ingredient, a plant extract which is highly safe and has acceptable levels of stability and odor or grout formation; and an agent for external...  
WO/2006/122447
A medicament for treating drugs abuse, whose molecular weight is less than 32000, comprises peroxidase 5-40 proportion by weight, superoxide dismutase 20-50 proportion by weight, catalase 5-20 proportion by weight. It is obtained from ma...  
WO/2006/123618
An oxidative stress inhibitor comprising a spherical activated carbon as an active ingredient. This inhibitor is effective for the prevention or treatment of a disease induced by oxidative stress, such as renal failure, a disease of the ...  
WO/2006/117181
The invention relates to the use of at least one thiamine for the prophylaxis and/or treatment of diseases, which are associated with DNA lesions, whereby the administration of thiamine leads to a reduction in the DNA lesions.  
WO/2006/117181
The invention relates to the use of at least one thiamine for the prophylaxis and/or treatment of diseases, which are associated with DNA lesions, whereby the administration of thiamine leads to a reduction in the DNA lesions.  
WO/2006/115202
[PROBLEMS] It is well known that nicotine contained in tobacco exerts an adverse health effect on smokers and passive smokers. Although many smokers want to stop smoking, there is only a low possibility of success due to the nicotine dep...  
WO/2006/111591
The invention relates to a method of obtaining a lycopene-rich formulation that is free of organic solvents. The inventive method comprises the following steps consisting in: (a) mixing a lycopene source with an extracting lipid, and (b)...  
WO/2006/111833
The present invention relates to the use of herbal formulation comprising the synergistic combination of fiber/powder/granules of the aerial parts of plants selected from Hemedesmus indicus, Acorus calamus, Murraya Koenigii, Alpinia gala...  
WO/2006/108595
Disclosed is the use of sporopollenin and/or the derivatives thereof as a component of medicaments or medical products for the therapeutic and/or prophylactic treatment and/or of food supplements for preventing side effects and/or poison...  
WO/2006/107626
Compounds represented by structural formulas described herein, such as Structural Formula (I): are useful in treating conditions such as metal overload, oxidative stress, and neoplastic and preneoplastic conditions.  
WO/2006/104397
Pharmaceutical compositions having a pharmaceutically acceptable copper antagonist(s) or a pharmaceutically acceptable salts or prodrugs thereof, including copper (II) antagonists, and a pharmaceutically acceptable anti-obesity agent or ...  
WO/2006/105440
Provided herein are sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders incl...  
WO/2006/104402
Pharmaceutical compositions having a pharmaceutically acceptable copper antagonist(s) or a pharmaceutically acceptable salts or prodrugs thereof, including copper (II) antagonists, and a pharmaceutically acceptable antihypertensive agent...  
WO/2006/103316
The object of the invention comprises food compositions, to which one or more acetalde- hyde-binding compounds are added. The purpose of the compositions is to reduce the amount of detrimental acetaldehyde in the area of the mouth, the p...  
WO/2006/105440
Provided herein are sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders incl...  
WO/2006/104154
Disclosed is a highly safe composition for enhancing expression and activity of a protease in the liver. Specifically disclosed is a composition containing coenzyme Q10 as an active constituent. This composition enhances expression and a...  
WO/2006/104153
Disclosed is a composition which serves to maintain a high level of reduced coenzyme Q10 in the blood upon intake of the coenzyme Q10 even in an elderly mammal to thereby maintain a high level of anti-oxidation activity in the blood. A c...  
WO/2006/101106
A precious metal nanocolloid solution comprising nanoparticles of a precious metal, such as platinum, gold or a mixture thereof, and a polysaccharide derived from natural products, such as pectin and chitosan. The precious metal nanocoll...  
WO/2006/095870
[PROBLEMS] To provide a novel photosensitizer, methods of cleaving a protein and cleaving a sugar molecule with light irradiation, and a protein-cleaving agent and sugar molecule-cleaving agent for use in these methods. [MEANS FOR SOLVIN...  
WO/2006/096577
Methods of preventing and treating opioid bowel dysfunction are disclosed. In addition, methods of increasing the frequency of spontaneous complete bowel movements, methods for improving the quality of life of a patient suffering from op...  
WO/2006/096577
Methods of preventing and treating opioid bowel dysfunction are disclosed. In addition, methods of increasing the frequency of spontaneous complete bowel movements, methods for improving the quality of life of a patient suffering from op...  
WO/2006/093124
It is intended to provide a novel free radical scavenger for removing active oxygen which is causative for various diseases in vivo and results in degradation and color fade-out in commercial products. A free radical scavenger which cont...  
WO/2006/093202
A phloroacyphenone glycoside represented by the general formula (1): wherein R1 represents an isopropyl, isobutyl or sec-butyl group.  
WO/2006/091010
Disclosed is a pharmaceutical composition for eliminating and alleviating alcohol -related disorders. The pharmaceutical composition for eliminating and alleviating alcohol -related disorders including hangover symptoms or flushing compr...  
WO/2006/089537
The invention relates to a method for production of an oral, rectal or vaginal preparation comprising a solid silicone oil emulsion, characterised in that said preparation comprises 0.01 - 85 wt. % dimethicone and 0.01 - 45 wt. % dimethy...  
WO/2006/090830
A composition containing, as the main component, a proanthocyanidin oligomer which is obtained by heating a plant material containing a proanthocyanidin polymer or its extract together with a substance having a phloroglucinol ring or res...  
WO/2006/089120
The present invention provides novel 2,6-diisopropyl phenol2,6-diisopropyl phenol analogs and sterile, stable pharmaceutical compositions of 2,6-diisopropyl phenol 2,6-diisopropyl phenol and analogs thereof useful as an antioxidant in th...  
WO/2006/088394
The invention relates to methods for producing humic substance-containing means which are used for protecting an organism against ionising radiation, is efficient in the form of a radioprotector and a therapeutic composition for accelera...  

Matches 601 - 650 out of 4,664